Drug Trial Radar · NCT00528970
A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair
Last checked: Nov 19, 2026Latest source record: Sep 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
374
Actual
Start
Oct 17, 2007
Primary completion
Feb 5, 2008
Study completion Feb 5, 2008
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Progenics Pharmaceuticals, Inc.
- First posted
- Sep 14, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and efficacy of two different dose regimens (12 milligrams \[mg\] and 24 mg) of IV MOA-728 versus placebo in shortening the time to return of bowel function in participants receiving opioid analgesia administered via patient-controlled anesthesia (PCA), and who had undergone repair of large (greater than or equal to \[≥\]10 centimeters) ventral hernias with or without a mesh prosthesis via laparotomy or laparoscopy.
Conditions
- Ileus
Interventions
MOA-728Drug
MOA-728 will be administered per the dose and schedule specified in the arm.
PlaceboDrug
Placebo matching to MOA-728 will be administered per the schedule specified in the arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Bowel MovementTime frame: Day 1 (From the time of end of surgery [that is; from the first dose of study drug administration]) up to Day 10
Locations
106 sites in 11 countries. Site status is shown where the registry gives one.
Site not named
Benton, Arkansas
Site not named
Colton, California
Site not named
Laguna Hills, California
Site not named
Loma Linda, California
Site not named
Long Beach, California
Site not named
Los Angeles, California
Site not named
Orange, California
Site not named
San Jose, California
Site not named
Santa Barbara, California
Site not named
Denver, Colorado
Site not named
Denver, Colorado
Site not named
Inverness, Florida
Site not named
Jacksonville, Florida
Site not named
Jacksonville, Florida
Site not named
Melbourne, Florida
Site not named
Miami, Florida
Site not named
Miami, Florida
Site not named
Naples, Florida
Site not named
Orlando, Florida
Site not named
Pensacola, Florida
Site not named
Tampa, Florida
Site not named
Peoria, Illinois
Site not named
Des Moines, Iowa
Site not named
Kansas City, Kansas
Site not named
Lexington, Kentucky
Site not named
Baltimore, Maryland
Site not named
Boston, Massachusetts
Site not named
Boston, Massachusetts
Site not named
Springfield, Massachusetts
Site not named
Ann Arbor, Michigan
Site not named
Detroit, Michigan
Site not named
Flint, Michigan
Site not named
Jackson, Mississippi
Site not named
Columbia, Missouri
Site not named
Omaha, Nebraska
Site not named
Omaha, Nebraska
Site not named
New Brunswick, New Jersey
Site not named
Albuquerque, New Mexico
Site not named
Albany, New York
Site not named
New York, New York
Showing 40 of 106 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.